1. Tamaki N, Takahashi N, Kawamoto M, Torizuka T, Tadamura E, Yonekura Y, et al. Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease.J Nucl Med 35: 594–600, 1994.
2. Sridhara BS, Braat S, Rigo P, Itti R, Cload P, Lahiri A, et al. Comparison of myocardial perfusion imaging with technetium-99m tetrofosmin versus thallium-201 in coronary artery disease.Am J Cardiol 72: 1015–1019, 1993.
3. Jain D, Wackers FJT, Mattera J, McMahon M, Sinusas AJ, Zaret BL. Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol.J Nucl Med 34: 1254–1259, 1993.
4. Zaret BL, Rigo P, Wackers FJT, Hendel RC, Braat SH, Iskandrian AS, et al. Myocardial perfusion imaging with99mTc tetrofosmin. Comparison to201Tl imaging and coronary angiography in a phase III multicenter trial.Circulation 91: 313–319, 1995.
5. Kinoshita N, Sugihara H, Nakamura T, Ito K, Azuma A, Maeda T, et al. A calculation of an index of the coronary flow reserve using exercise and rest myocardial SPECT with99mTc-tetrofosmin.KAKU IGAKU (Jpn J Nucl Med) 34: 45–48, 1997.